X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8540) 8540
Newsletter (43) 43
Book Chapter (23) 23
Magazine Article (7) 7
Dissertation (5) 5
Newspaper Article (4) 4
Publication (3) 3
Book / eBook (2) 2
Book Review (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5923) 5923
alzheimer's disease (5259) 5259
neurosciences (3770) 3770
male (3065) 3065
animals (2834) 2834
female (2753) 2753
amyloid beta-peptides - metabolism (2437) 2437
aged (2435) 2435
alzheimers-disease (2257) 2257
amyloid beta-peptides - cerebrospinal fluid (2137) 2137
dementia (1817) 1817
alzheimer disease - metabolism (1802) 1802
clinical neurology (1741) 1741
middle aged (1718) 1718
brain (1703) 1703
cerebrospinal-fluid (1622) 1622
alzheimer’s disease (1517) 1517
neurology (1496) 1496
alzheimer disease - cerebrospinal fluid (1467) 1467
alzheimer disease - pathology (1419) 1419
tau proteins - cerebrospinal fluid (1387) 1387
peptide fragments - cerebrospinal fluid (1374) 1374
cerebrospinal fluid (1358) 1358
mild cognitive impairment (1351) 1351
aged, 80 and over (1332) 1332
biomarkers (1326) 1326
biomarkers - cerebrospinal fluid (1280) 1280
mice (1262) 1262
a-beta (1211) 1211
neurodegenerative diseases (1207) 1207
alzheimers disease (1195) 1195
brain - metabolism (1162) 1162
proteins (1131) 1131
amyloid precursor protein (1115) 1115
biochemistry & molecular biology (1041) 1041
alzheimer disease - diagnosis (1026) 1026
pathology (1008) 1008
amyloid-beta (1000) 1000
alzheimer disease - genetics (973) 973
amyloid (887) 887
amyloid beta-protein (883) 883
research (867) 867
peptides (850) 850
diagnosis (840) 840
tau (829) 829
brain - pathology (820) 820
neurodegeneration (816) 816
mouse model (759) 759
β-amyloid (757) 757
oxidative stress (725) 725
alzheimer disease - drug therapy (720) 720
alzheimer disease (713) 713
disease models, animal (713) 713
protein (707) 707
mice, transgenic (699) 699
cognitive ability (684) 684
cell biology (648) 648
geriatrics & gerontology (641) 641
transgenic mice (638) 638
psychiatry (635) 635
alzheimer disease - physiopathology (633) 633
phosphorylation (624) 624
analysis (616) 616
precursor protein (609) 609
disease (577) 577
risk factors (577) 577
memory (558) 558
rats (556) 556
tau protein (553) 553
disease progression (545) 545
magnetic resonance imaging (539) 539
peptide fragments - metabolism (537) 537
multidisciplinary sciences (536) 536
physiological aspects (533) 533
peptide (528) 528
enzyme-linked immunosorbent assay (520) 520
in-vivo (518) 518
central-nervous-system (513) 513
apolipoprotein-e (511) 511
tau proteins - metabolism (509) 509
beta-amyloid (508) 508
inflammation (502) 502
neuropsychological tests (500) 500
amyloid beta-protein precursor - metabolism (499) 499
adult (497) 497
aging (495) 495
mental disorders (493) 493
neurons (486) 486
research article (482) 482
review (481) 481
pharmacology & pharmacy (471) 471
pathogenesis (470) 470
amyloid beta-peptides - blood (463) 463
amyloid-beta-peptide (449) 449
medicine (446) 446
neuroscience (434) 434
health aspects (429) 429
neurons - metabolism (429) 429
rodents (428) 428
development and progression (427) 427
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8533) 8533
Japanese (38) 38
German (26) 26
French (16) 16
Chinese (10) 10
Spanish (10) 10
Russian (8) 8
Dutch (3) 3
Polish (3) 3
Danish (2) 2
Finnish (2) 2
Italian (1) 1
Norwegian (1) 1
Portuguese (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 370, Issue 4, pp. 322 - 333
In two phase 3 trials in patients with Alzheimer's disease, bapineuzumab, a humanized anti–amyloid-beta monoclonal antibody, did not improve clinical outcomes.... 
ANTIBODIES | MEDICINE, GENERAL & INTERNAL | EPITOPE | IMAGING ABNORMALITIES | PEPTIDE | MOUSE MODEL | Phosphorylation | Humans | Middle Aged | Male | Positron-Emission Tomography | Treatment Failure | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Female | Severity of Illness Index | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Biomarkers - analysis | Alzheimer Disease - drug therapy | tau Proteins - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Cognition - drug effects | Neuropsychological Tests | Amyloid beta-Peptides - antagonists & inhibitors | Apolipoproteins E - genetics | Intention to Treat Analysis | Amyloid beta-Peptides - analysis | Brain - pathology | Aged | Biomarkers - cerebrospinal fluid | Edema - chemically induced | Alzheimer Disease - genetics | Monoclonal antibodies | Product development | Research | Drug therapy | Alzheimer's disease | Health aspects | Edema | Nuclear magnetic resonance--NMR | Intravenous administration | Neurodegenerative diseases | Cognitive ability | Clinical trials | Cerebrospinal fluid | Patients | Studies | Tau protein | Apolipoprotein E | Immunotherapy | Alleles | Dementia disorders | Alzheimers disease | Brain | Neurosciences | pathology | Biological Markers | Antibodies | Cognition | tau Proteins | 80 and over | genetics | Amyloid beta-Peptides | Apolipoproteins E | Monoclonal | Neurovetenskaper | drug therapy | chemically induced | Humanized | drug effects | Alzheimer Disease | analysis | antagonists & inhibitors | cerebrospinal fluid | adverse effects | therapeutic use
Journal Article
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, ISSN 0022-3565, 07/2016, Volume 358, Issue 1, pp. 138 - 150
Journal Article
by Mattsson, Niklas and Andreasson, Ulf and Persson, Staffan and Arai, Hiroyuki and Batish, Sat Dev and Bernardini, Sergio and Bocchio-Chiavetto, Luisella and Blankenstein, Marinus A and Carrillo, Maria C and Chalbot, Sonia and Coart, Els and Chiasserini, Davide and Cutler, Neal and Dahlfors, Gunilla and Duller, Stefan and Fagan, Anne M and Forlenza, Orestes and Frisoni, Giovanni B and Galasko, Douglas and Galimberti, Daniela and Hampel, Harald and Handberg, Aase and Heneka, Michael T and Herskovits, Adrianna Z and Herukka, Sanna-Kaisa and Holtzman, David M and Humpel, Christian and Hyman, Bradley T and Iqbal, Khalid and Jucker, Mathias and Kaeser, Stephan A and Kaiser, Elmar and Kapaki, Elisabeth and Kidd, Daniel and Klivenyi, Peter and Knudsen, Cindy S and Kummer, Markus P and Lui, James and LladÓ, Albert and Lewczuk, Piotr and Li, Qiao-Xin and Martins, Ralph and Masters, Colin and McAuliffe, John and Mercken, Marc and Moghekar, Abhay and Molinuevo, JosÉ Luis and Montine, Thomas J and Nowatzke, William and O'Brien, Richard and Otto, Markus and Paraskevas, George P and Parnetti, Lucilla and Petersen, Ronald C and Prvulovic, David and de Reus, Herman P.M and Rissman, Robert A and Scarpini, Elio and Stefani, Alessandro and Soininen, Hilkka and Schröder, Johannes and Shaw, Leslie M and Skinningsrud, Anders and Skrogstad, Brith and Spreer, Annette and Talib, Leda and Teunissen, Charlotte and Trojanowski, John Q and Tumani, Hayrettin and Umek, Robert M and Van Broeck, Bianca and Vanderstichele, Hugo and Vecsei, Laszlo and Verbeek, Marcel M and Windisch, Manfred and Zhang, Jing and Zetterberg, Henrik and Blennow, Kaj and Sahlgrenska akademin and Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi and Göteborgs universitet and Gothenburg University and Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry and Sahlgrenska Academy
Alzheimer's & dementia, ISSN 1552-5260, 2011, Volume 7, Issue 4, pp. 386 - 395.e6
Journal Article
Neuron (Cambridge, Mass.), ISSN 0896-6273, 2013, Volume 80, Issue 6, pp. 1347 - 1358
Journal Article